NUVOQ.US Holdco Nuvo Group D.G Ltd
- Market cap
- USD 120K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2023.
Is NUVOQ.US undervalued?
Graham numberThe Graham number of Holdco Nuvo Group D.G Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Holdco Nuvo Group D.G Ltd fundamental analysis
No fundamental analysis for Holdco Nuvo Group D.G Ltd yet.
Holdco Nuvo Group D.G Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Holdco Nuvo Group D.G Ltd
Holdco Nuvo Group D.G Ltd engages in the research and development of medical devices for pregnancy monitoring in Israel, the United States, and internationally. The company provides the INVU platform, a remote pregnancy monitoring system that offers mothers and doctors the information needed to complete fetal monitoring remotely. Its INVU platform includes a self-administered wireless sensor band that clinicians prescribe to expectant mothers to wear during virtual visits to…
Full company profileHoldco Nuvo Group D.G Ltd financial statements
Holdco Nuvo Group D.G Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 0.00 | 0.00 | 176K |
| Gross Profit | 0.00 | 0.00 | -15.0K |
| Operating Income | -27.6M | -20.8M | -16.6M |
| EBITDA | -33.3M | -19.3M | -34.4M |
| Net Income | -34.5M | -20.7M | -33.7M |
| EPS | -1.04 | -0.62 | -1.01 |
| Balance Sheet | |||
| Total Assets | 7.44M | 3.75M | 3.49M |
| Total Liabilities | 33.3M | 42.5M | 71.0M |
| Shareholders' Equity | -25.8M | -38.7M | -67.5M |
| Cash & Short-term Investments | 4.60M | 837K | 553K |
| Cash Flow | |||
| Operating Cash Flow | -14.4M | -13.5M | -15.0M |
| Capital Expenditure | 238K | 253K | 38.0K |
| Free Cash Flow | -14.6M | -13.7M | -15.0M |
| Ratios | |||
| ROA | -463.9% | -551.7% | -965.4% |
| Net Profit Margin | - | - | -19,122.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Holdco Nuvo Group D.G Ltd dividends
Holdco Nuvo Group D.G Ltd has not paid dividends in the last 3 fiscal years.
Who owns Holdco Nuvo Group D.G Ltd
Ownership data of Holdco Nuvo Group D.G Ltd is not available yet.
Holdco Nuvo Group D.G Ltd company profile
- Company name
- Holdco Nuvo Group D.G Ltd
- Ticker
- NUVOQ.US
- ISIN
- IL0012023656
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 42
- Fiscal year end
- December
- Address
- Alon Tower 1, Tel Aviv-Yafo, Israel, 6789155
- Phone
- 972 7 3471 72416
- Website
- nuvocares.com
About Holdco Nuvo Group D.G Ltd
Holdco Nuvo Group D.G Ltd engages in the research and development of medical devices for pregnancy monitoring in Israel, the United States, and internationally. The company provides the INVU platform, a remote pregnancy monitoring system that offers mothers and doctors the information needed to complete fetal monitoring remotely. Its INVU platform includes a self-administered wireless sensor band that clinicians prescribe to expectant mothers to wear during virtual visits to capture real-time data on key maternal and fetal health metrics and perform a non-stress test. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd, incorporated, is based in Tel Aviv-Yafo, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Holdco Nuvo Group D.G Ltd management
5- Mr. Marcel HandlerPresident
- Muhammad MhajnaChief Technical Officer
- Mr. Scott LamSenior Vice President of Sales
- Craig AllisonChief Marketing Officer
- Dr. Richard Broth M.D.Chief Medical Officer